Managed Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or large B-cell lymphoma patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release
This Study is
No Longer Enrolling
Details
Age
Child to Adult
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Treatment
Locations
Childrens Hospital Colorado
Study ID
Protocol Number: 18-1943
More information available at ClinicalTrials.gov: NCT03601442
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers